Constellium (NYSE: CSTM) posts strong Q1 2026 earnings jump and boosts buybacks
Constellium reported a very strong first quarter of 2026, with revenue up 24% to $2,461 million from $1,979 million a year earlier, driven mainly by higher revenue per ton and aluminum prices, with shipments roughly flat at 370 kt.
Net income jumped to $196 million from $38 million, and basic earnings per share rose to $1.47 from $0.26. Adjusted EBITDA increased to $359 million, including $97 million of metal price lag, as all three segments improved profitability, particularly Packaging & Automotive Rolled Products.
Operating cash flow improved to $73 million despite higher inventories and receivables tied to higher metal prices and activity. Liquidity remained solid at $904 million, and the company repurchased 1.2 million shares for $28 million while continuing to invest $68 million in capital expenditures.
Positive
- Strong earnings inflection: Q1 2026 net income rose to $196 million from $38 million, with Adjusted EBITDA nearly doubling to $359 million, reflecting broad-based margin expansion across segments.
- Segment outperformance in P&ARP: Packaging & Automotive Rolled Products Segment Adjusted EBITDA increased from $60 million to $151 million, with EBITDA per ton rising from $223 to $578.
- Solid liquidity and capital returns: Total liquidity stood at $904 million while the company repurchased 1.2 million shares for $28 million and continued to invest $68 million in capex.
Negative
- None.
Insights
Q1 2026 shows sharply higher earnings, strong cash generation, and solid liquidity.
Constellium delivered a powerful earnings step-up. Revenue rose to $2,461 million with limited volume change, indicating strong pricing and metal pass-through. Net income of $196 million and Adjusted EBITDA of $359 million more than doubled year over year.
Segment data highlight especially strong performance in P&ARP, where Segment Adjusted EBITDA climbed from $60 million to $151 million, helped by favorable metal costs and pricing. A&T and AS&I also improved EBITDA through higher volumes or lower costs, despite mixed volume trends.
Operating cash flow of $73 million improved even as inventories and receivables increased with higher aluminum prices and activity. Liquidity of $904 million and continued share repurchases of $28 million suggest confidence in the balance sheet. Future quarters will reflect how metal prices, derivatives results and macro demand trends evolve within these markets.
Key Figures
Key Terms
Segment Adjusted EBITDA financial
metal price lag financial
factoring arrangements financial
cash flow hedges financial
Performance-Based Restricted Stock Units (PSUs) financial
Pan-U.S. ABL facility financial
(Mark One) | |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||
300 East Lombard Street, Suite 1710 | ||||||
(Zip Code) | ||||||
(Address of principal executive office (US)) | ||||||
(Registrant's telephone number, including area code) | ||||||
Securities registered pursuant to section 12(b) of the Act | ||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||
☑ | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Page | |||
PART 1 | |||
Item 1. | Financial Statements | 1 | |
Consolidated Income Statements (unaudited) | 1 | ||
Consolidated Statements of Comprehensive Income (unaudited) | 2 | ||
Consolidated Balance Sheets (unaudited) | 3 | ||
Consolidated Statements of Changes in Equity (unaudited) | 4 | ||
Consolidated Statements of Cash Flows (unaudited) | 5 | ||
Notes to the Unaudited Interim Condensed Consolidated Financial Statements | 6 | ||
Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 23 | |
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 33 | |
Item 4. | Controls and Procedures | 33 | |
PART II | |||
Item 1. | Legal Proceedings | 34 | |
Item 1A. | Risk Factors | 34 | |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 34 | |
Item 3. | Defaults Upon Senior Securities | 34 | |
Item 4. | Mine Safety Disclosures | 34 | |
Item 5. | Other Information | 35 | |
Item 6. | Exhibits | 35 | |
SIGNATURES | 36 | ||
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Revenue | 2 | |||||
Cost of sales (excluding depreciation and amortization) | ( | ( | ||||
Depreciation and amortization | ( | ( | ||||
Selling and administrative expenses | ( | ( | ||||
Research and development expenses | ( | ( | ||||
Other gains and losses – net | 4 | ( | ||||
Finance costs – net | 5 | ( | ( | |||
Income before tax | ||||||
Income tax expense | 6 | ( | ( | |||
Net income | ||||||
Attributable to: | ||||||
Equity holders of Constellium | ||||||
Non-controlling interests | ( | |||||
Net income | ||||||
Earnings per share attributable to the equity holders of Constellium (in U.S. dollars) | Notes | |||||
Basic | 7 | |||||
Diluted | 7 |
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Net income | ||||||
Other comprehensive (loss) / income | ||||||
Net change in post-employment benefit obligations | ( | ( | ||||
Income tax on net change in post-employment benefit obligations | ||||||
Net change in cash flow hedges | 12 | ( | ||||
Income tax on cash flow hedges | ( | |||||
Currency translation adjustments | ( | |||||
Other comprehensive (loss) / income | ( | |||||
Total comprehensive income | ||||||
Attributable to: | ||||||
Equity holders of Constellium | ||||||
Non-controlling interests | ( | |||||
Total comprehensive income | ||||||
(in millions of U.S. dollars) except share data and as otherwise stated | Notes | At March 31, 2026 | At December 31, 2025 | |||
Assets | ||||||
Current assets | ||||||
Cash and cash equivalents | ||||||
Trade receivables and other, net | 8 | |||||
Inventories | 9 | |||||
Fair value of derivatives instruments and other financial assets | ||||||
Total current assets | ||||||
Non-current assets | ||||||
Property, plant and equipment, net | ||||||
Goodwill | ||||||
Intangible assets, net | ||||||
Deferred tax assets | ||||||
Trade receivables and other, net | 8 | |||||
Fair value of derivatives instruments | 12 | |||||
Total non-current assets | ||||||
Total assets | ||||||
Liabilities | ||||||
Current liabilities | ||||||
Trade payables and other | 10 | |||||
Current portion of long-term debt | 11 | |||||
Fair value of derivatives instruments | 12 | |||||
Income tax payable | ||||||
Pension and other benefit obligations | ||||||
Provisions | 14 | |||||
Total current liabilities | ||||||
Non-current liabilities | ||||||
Trade payables and other | 10 | |||||
Long-term debt | 11 | |||||
Fair value of derivatives instruments | 12 | |||||
Pension and other benefit obligations | ||||||
Provisions | 14 | |||||
Deferred tax liabilities | ||||||
Total non-current liabilities | ||||||
Total liabilities | ||||||
Commitments and contingencies | 14 | |||||
Shareholders' equity | ||||||
Ordinary shares, par value € at December 31, 2025; 31, 2026 and at December 31, 2025, respectively | ||||||
Additional paid in capital | ||||||
Accumulated other comprehensive income | 15 | |||||
Retained earnings | ||||||
Treasury shares 2025 | ( | ( | ||||
Equity attributable to equity holders of Constellium | ||||||
Non-controlling interests | ||||||
Total equity | ||||||
Total equity and liabilities |
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2026 | ( | |||||||||||||||
Net income | — | — | — | — | — | ( | ||||||||||
Other comprehensive loss | — | — | — | ( | — | — | — | ( | ||||||||
Total comprehensive (loss) / income | — | — | — | ( | — | ( | ||||||||||
Share issuance | — | — | — | — | — | — | — | |||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | ( | — | |||||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At March 31, 2026 | ( | |||||||||||||||
in millions of U.S. dollars, except share amounts | Ordinary shares outstanding | Ordinary shares | Treasury shares | Accumulated other comprehensive income / (loss) | Additional paid in capital | Retained earnings | Non- controlling interests | Total equity | ||||||||
At January 1, 2025 | ( | ( | ||||||||||||||
Net income | — | — | — | — | — | |||||||||||
Other comprehensive income | — | — | — | — | — | — | ||||||||||
Total comprehensive income | — | — | — | — | ||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||
Repurchase of ordinary shares | ( | — | ( | — | — | — | — | ( | ||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | ( | — | |||||||||||
Other | — | — | — | — | ( | — | ||||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | ( | ( | ||||||||
At March 31, 2025 | ( | ( |
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Net income | ||||||
Adjustments | ||||||
Depreciation and amortization | 3 | |||||
Impairment of assets | 3 | |||||
Pension and other long-term benefits | ||||||
Finance costs - net | 5 | |||||
Income tax expense | ||||||
Unrealized (gains) /losses on derivatives - net and from remeasurement of monetary assets and liabilities - net | ( | |||||
Other - net | ||||||
Changes in working capital | ||||||
Inventories | ( | ( | ||||
Trade receivables | ( | ( | ||||
Trade payables | ||||||
Other | ( | ( | ||||
Change in provisions | ( | |||||
Pension and other long-term benefits paid | ( | ( | ||||
Interest paid | ( | ( | ||||
Income tax paid | ( | ( | ||||
Net cash flows from operating activities | ||||||
Purchases of property, plant and equipment | 3 | ( | ( | |||
Property, plant and equipment inflows | 3 | |||||
Collection of deferred purchase price receivable | 8 | |||||
Net cash flows used in investing activities | ( | ( | ||||
Repurchase of ordinary shares | ( | ( | ||||
Repayments of long-term debt | ( | ( | ||||
Net change in revolving credit facilities and short-term debt | ||||||
Finance lease repayments | ( | ( | ||||
Transactions with non-controlling interests | ( | ( | ||||
Other financing activities | ( | |||||
Net cash flows from / (used in) financing activities | ( | |||||
Net increase / (decrease) in cash and cash equivalents | ( | |||||
Cash and cash equivalents - beginning of year | ||||||
Net increase / (decrease) in cash and cash equivalents | ( | |||||
Effect of exchange rate changes on cash and cash equivalents | ( | |||||
Cash and cash equivalents - end of period | ||||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Aerospace rolled products | ||||
Transportation, industry, defense and other rolled products | ||||
Packaging rolled products | ||||
Automotive rolled products | ||||
Specialty and other thin-rolled products | ||||
Automotive extruded products | ||||
Other extruded products | ||||
Total revenue | ||||
Three months ended March 31, | ||||||||||
2026 | 2025 | |||||||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | H&C (B) | A&T | P&ARP | AS&I | H&C (B) | ||
Segment revenue | ||||||||||
Inter-segment elimination | ( | ( | ( | ( | ( | ( | ||||
External revenue | ||||||||||
Cost of metal | ( | ( | ( | ( | ( | ( | ||||
Production costs | ( | ( | ( | ( | ( | ( | ( | ( | ||
Other segment expenses (A) | ( | ( | ( | ( | ( | ( | ( | ( | ||
Segment Adjusted EBITDA | ( | ( | ||||||||
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
A&T | ||||||
P&ARP | ||||||
AS&I | ||||||
H&C (A) | ( | ( | ||||
Segment Adjusted EBITDA | ||||||
Metal price lag (B) | ||||||
Depreciation and amortization | ( | ( | ||||
Impairment of assets | ( | |||||
Share based compensation | 16 | ( | ( | |||
Pension and other post-employment benefits - non - operating gains | ||||||
Restructuring costs | ( | ( | ||||
Unrealized gains / (losses) on derivatives | ( | |||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | ( | |||||
Other (C) | ||||||
Expenses on factoring arrangements | 8 | ( | ( | |||
Finance costs – net | 5 | ( | ( | |||
Income before tax | ||||||
Income tax expense | 6 | ( | ( | |||
Net income | ||||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
A&T | ( | ( | ||
P&ARP | ( | ( | ||
AS&I | ( | ( | ||
Total capital expenditures (A) | ( | ( | ||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
A&T | ( | ( | ||
P&ARP | ( | ( | ||
AS&I | ( | ( | ||
H&C (A) | ( | ( | ||
Total depreciation, amortization and impairment expense | ( | ( | ||
(in millions of U.S. dollars) | At March 31, 2026 | At December 31, 2025 | ||
A&T | ||||
P&ARP | ||||
AS&I | ||||
H&C (A) | ||||
Deferred income tax assets | ||||
Cash and cash equivalents | ||||
Fair value of derivatives instruments and other financial assets | ||||
Total assets |
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Operating income and expenses | ||||||
Realized gains / (losses) on derivatives (A) | ||||||
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net (A) | 12 | ( | ||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | ( | |||||
Impairment of assets | ( | |||||
Restructuring costs | ( | ( | ||||
Result from the flood in Valais | 3 | |||||
Non-operating income and expenses | ||||||
Expenses on factoring arrangements | 8 | ( | ( | |||
Pension and other post-employment benefits | 13 | |||||
Other | ||||||
Total other gains and losses - net | ( | |||||
Three months ended March 31, | ||||||
(in millions of U.S. dollars) | Notes | 2026 | 2025 | |||
Interest expense on borrowings (A) | ( | ( | ||||
Interest cost on pension and other long-term benefits | 13 | ( | ( | |||
Realized and unrealized (losses) / gains on debt derivatives at fair value (B) | 12 | ( | ||||
Realized and unrealized exchange (losses) / gains on financing activities - net (B) | ( | |||||
Other finance expenses | ( | ( | ||||
Capitalized borrowing costs (C) | ||||||
Finance expenses | ( | ( | ||||
Finance costs - net | ( | ( | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars except share and per share amounts ) | 2026 | 2025 | ||
Numerator: | ||||
Net income attributable to equity holders of Constellium | ||||
Denominator: | ||||
Basic - weighted-average ordinary shares outstanding | ||||
Dilutive effect of non-vested restricted stock units and performance-based restricted stock units | ||||
Diluted - weighted-average ordinary shares, of restricted stock units and performance- based restricted stock units | ||||
Basic earnings per share | $ | $ | ||
Diluted earnings per share | $ | $ | ||
At March 31, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade receivables - gross | ||||
Allowance for credit losses | ( | ( | ||
Total trade receivables - net | ||||
Total other receivables | ||||
Total trade receivables and other |
(in millions of U.S. dollars) | At March 31, 2026 | At December 31, 2025 | ||
Finished goods | ||||
Work in progress | ||||
Raw materials | ||||
Stores and supplies | ||||
Total inventories |
At March 31, 2026 | At December 31, 2025 | |||
(in millions of U.S. dollars) | Current | Current | ||
Trade payables | ||||
Employees' entitlements | ||||
Other payables | ||||
Total other | ||||
Total trade payables and other |
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Contract liabilities and other liabilities to customers at January 1, | ||||
Revenue deferred to contract liabilities | ||||
Revenue recognized from contract liabilities | ( | ( | ||
Effect of changes in foreign currency rates and other changes | ( | |||
Contract liabilities and other liabilities to customers at March 31, | ||||
At March 31, 2026 | At December 31, 2025 | |||||||||
(in millions of U.S. dollars) | Nominal Value in Currency | Nominal rate | Effective rate | Face Value | Debt issuance costs | Accrued interest | Carrying value | Carrying value | ||
Secured Pan-U.S. ABL (due 2029) | $ | Floating | ||||||||
Senior Unsecured Notes | ||||||||||
Issued June 2020 and due 2028 | $ | ( | ||||||||
Issued February 2021 and due 2029 | $ | ( | ||||||||
Issued June 2021 and due 2029 | € | ( | ||||||||
Issued August 2024 and due 2032 | $ | ( | ||||||||
Issued August 2024 and due 2032 | € | ( | ||||||||
Finance lease liabilities | ||||||||||
Other loans | ( | |||||||||
Total debt | ( | |||||||||
Of which non-current | ||||||||||
Of which current (A) | ||||||||||
At March 31, 2026 | At December 31, 2025 | |||||||||||
(in millions of U.S. dollars) | Non- current | Current | Total | Non- current | Current | Total | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Currency net debt derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivatives instruments - assets | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivatives instruments - liabilities | ||||||||||||
At March 31, 2026 | At December 31, 2025 | |||||||||||||||
(in millions of U.S. dollars) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||
Fair value of derivatives instruments - assets | ||||||||||||||||
Fair value of derivatives instruments - liabilities | ||||||||||||||||
Sold currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2026-2031 | |||||
CHF | 2026-2029 | |||||
CZK | 2026 | |||||
Other currencies | 2026-2027 |
Purchased currencies | ||||||
USD | 2026-2027 | |||||
CHF | 2026-2028 | |||||
CZK | 2026-2027 | |||||
Other currencies | 2026 |
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Derivatives that do not qualify for hedge accounting | ||||
Included in Other gains and losses - net | ||||
Realized gains / (losses) on foreign currency derivatives - net (A) | ( | |||
Unrealized (losses) / gains on foreign currency derivatives - net (B) | ( | |||
Derivatives that qualify for hedge accounting | ||||
Included in Other comprehensive income | ||||
Unrealized (losses) / gains on foreign currency derivatives - net | ( | |||
(Losses) / gains reclassified from cash flow hedge reserve to the Consolidated Income Statement | ( | |||
Included in Revenue (C) | ||||
Realized gains / (losses) on foreign currency derivatives - net (A) | ( | |||
Unrealized gains on foreign currency derivatives - net | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Derivatives that do not qualify for hedge accounting | ||||
Included in Finance costs - net | ||||
Realized gains / (losses) on foreign currency derivatives - net (A) | ( | |||
Unrealized gains / (losses) on foreign currency derivatives - net | ||||
Total | ( | |||
(in millions of U.S. dollars) | Maturity Year | Less than 1 year | Over 1 year | |||
Metal | 2026-2028 | ( | ||||
Natural gas | 2026-2028 |
Three months ended March 31, | ||||
(in millions of U.S. dollar) | 2026 | 2025 | ||
Derivatives that do not qualify for hedge accounting | ||||
Included in Other gains and losses - net | ||||
Realized gains / (losses) on commodities derivatives - net (A) | ||||
Unrealized gains / (losses) on commodities derivatives - net | ( | |||
Three months ended March 31, | |||||||
2026 | 2025 | ||||||
(in millions of U.S. dollars) | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | |||
Current service cost | ( | ( | ( | ( | |||
Interest cost | ( | ( | ( | ( | |||
Expected return on plan assets | |||||||
Amortization of past service gain | |||||||
Total net pension and other long-term benefit cost | ( | ( | |||||
At March 31, 2026 | At December 31, 2025 | |||||||
(in millions of U.S. dollars) | Current | Non-current | Current | Non-current | ||||
Close down and environmental remediation costs | ||||||||
Restructuring costs | ||||||||
Legal claims and other costs | ||||||||
Total provisions | ||||||||
Three months ended March 31, 2026 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2026 | ( | |||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | ( | ||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ( | |||||
At March 31, 2026 | ( | |||||||
Three months ended March 31, 2025 | ||||||||
(in millions of U.S. dollars) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2025 | ( | ( | ( | |||||
Other comprehensive income / (loss) before reclassification | ||||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to the income statement | ( | ( | ||||||
Amounts reclassified from accumulated other comprehensive income / (loss) to retained earnings | ||||||||
At March 31, 2025 | ( | ( | ( | |||||
2026 PSUs | ||
Fair value at grant date (in dollars) | ||
Share price at grant date (in dollars) | ||
Dividend yield | ||
Expected volatility (A) | ||
Risk-free interest rate (US government bond yield) |
Three months ended March 31, 2026 | ||||
(as a % of total) | Revenue | Segment Adjusted EBITDA | ||
A&T | 25% | 39% | ||
P&ARP | 60% | 58% | ||
AS&I | 17% | 9% | ||
H&C (1) | —% | (6)% | ||
Total | 100% | 100% | ||
Three months ended March 31, | Percent changes QTD | |||||
(U.S. dollars per ton) | 2026 | 2025 | 2026 vs 2025 | |||
Average LME transaction price | 3,199 | 2,627 | 22% | |||
Average Midwest premium | 2,296 | 712 | 222% | |||
Average all-in aluminum price U.S. | 5,495 | 3,339 | 65% | |||
Average LME transaction price | 3,199 | 2,627 | 22% | |||
Average Rotterdam premium | 392 | 290 | 35% | |||
Average all-in aluminum price Europe | 3,591 | 2,917 | 23% | |||
Three months ended March 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | ||||||
Revenue | 2,461 | 100% | 1,979 | 100% | ||||
Cost of sales (excluding depreciation and amortization) | (2,041) | 83% | (1,716) | 87% | ||||
Depreciation and amortization | (83) | 3% | (78) | 4% | ||||
Selling and administrative expenses | (97) | 4% | (78) | 4% | ||||
Research and development expenses | (13) | 1% | (13) | 1% | ||||
Other gains and losses – net | 73 | 3% | (5) | —% | ||||
Finance costs – net | (28) | 1% | (27) | 1% | ||||
Income before tax | 272 | 11% | 62 | 3% | ||||
Income tax expense | (76) | 3% | (24) | 1% | ||||
Net income | 196 | 8% | 38 | 2% | ||||
Shipment volumes (in kt) | 370 | n/a | 372 | n/a | ||||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Realized gains / (losses) on foreign currency derivatives - net | 1 | (3) | ||
Realized gains on commodities derivatives - net | 37 | 9 | ||
Realized gains / (losses) on derivatives | 38 | 6 | ||
Unrealized (losses) / gains on foreign currency derivatives - net | (12) | 15 | ||
Unrealized gains / (losses) on commodities derivatives - net | 54 | (27) | ||
Unrealized gains / (losses) on derivatives at fair value through profit and loss - net | 42 | (12) | ||
Three months ended March 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | ||||||
A&T | 609 | 25% | 468 | 24% | ||||
P&ARP | 1,477 | 60% | 1,187 | 60% | ||||
AS&I | 415 | 17% | 381 | 19% | ||||
H&C (1) | 2 | —% | — | —% | ||||
Inter-segment eliminations | (42) | n.m | (57) | n.m | ||||
Total revenue | 2,461 | 100% | 1,979 | 100% | ||||
Three months ended March 31, | ||||||||
(in kt and as a % of shipments) | 2026 | 2025 | ||||||
A&T | 60 | 16% | 51 | 14% | ||||
P&ARP | 261 | 71% | 269 | 72% | ||||
AS&I | 51 | 14% | 52 | 14% | ||||
Inter-segment eliminations | (2) | n.m | — | n.m | ||||
Total shipments | 370 | 100% | 372 | 100% | ||||
Three months ended March 31, | ||||||||
(in millions of U.S. dollars and as a % of revenue) | 2026 | 2025 | ||||||
A&T | 102 | 17% | 82 | 18% | ||||
P&ARP | 151 | 10% | 60 | 5% | ||||
AS&I | 24 | 6% | 16 | 4% | ||||
(in millions of U.S. dollars) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the three months ended March 31, 2025 | 82 | 60 | 16 | |||
Volume | 32 | (6) | (4) | |||
Price and product mix | (2) | 26 | (2) | |||
Costs | (16) | 65 | 11 | |||
Foreign exchange and other | 6 | 6 | 3 | |||
Segment Adjusted EBITDA for the three months ended March 31, 2026 | 102 | 151 | 24 |
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Net Cash Flows from / (used in) | ||||
Operating activities | 73 | 58 | ||
Investing activities | (68) | (59) | ||
Financing activities | 20 | (26) | ||
Net (decrease) / increase in cash and cash equivalents, excluding the effect of exchange rate changes | 25 | (27) | ||
Three months ended March 31, | ||||
(in millions of U.S. dollars) | 2026 | 2025 | ||
Net income | 196 | 38 | ||
Income tax expense | 76 | 24 | ||
Finance costs – net | 28 | 27 | ||
Expenses on factoring arrangements | 4 | 5 | ||
Depreciation and amortization | 83 | 78 | ||
Restructuring costs | 3 | 1 | ||
Unrealized gains on derivatives | (42) | 12 | ||
Unrealized exchange gains from the remeasurement of monetary assets and liabilities – net | (1) | 1 | ||
Pension and other post-employment benefits - non - operating gains | (3) | (3) | ||
Share based compensation | 11 | 6 | ||
Gains / (losses) on disposal | — | — | ||
Other (A) | — | (3) | ||
Adjusted EBITDA1 | 359 | 186 | ||
of which Metal price lag (B) | 97 | 39 | ||
Period | Total number of shares purchased | Average price paid per share (in U.S. dollars) | Total number of shares purchased as part of publicly announced plans or programs | Maximum approximate dollar value of shares that may yet be purchased under the program | ||||
January 1 - January 31, 2026 | 354,931 | 20.48 | 354,931 | 98,851,993 | ||||
February 1 - February 28, 2026 | 509 | 21.99 | 509 | 98,840,801 | ||||
March 1 - March 31, 2026 | 796,635 | 25.10 | 796,635 | 78,841,643 | ||||
Total | 1,152,075 | 1,152,075 | 78,841,643 |
Exhibit | Description |
10.1 | 2026 Long Term Incentive Award Agreement, effective as from March 12, 2026** |
10.2 | Form of 2026 Long Term Incentive Award Letter for a grant of Restricted Stock Units** |
10.3 | Form of 2026 Long Term Incentive Award Letter for a grant of Restricted Stock Units and Performance Share Units** |
31.1 | Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** |
31.2 | Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002** |
32.1 | Certification by Chief Executive Officer of Constellium SE, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |
32.2 | Certification by Chief Financial Officer of Constellium SE, as required pursuant to Section 906 of the Sarbanes-Oxley Act of 2002* |
101.INS | Inline XBRL Instance Document** |
101.SCH | Inline XBRL Taxonomy Extension Schema Document** |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document** |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document** |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document** |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document** |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)** |
Constellium SE | |||
Date: | April 29, 2026 | By: | /s/ Ingrid Joerg |
Name: Ingrid Joerg | |||
Title: Chief Executive Officer and Director | |||
Date: | April 29, 2026 | By: | /s/ Jack Guo |
Name: Jack Guo | |||
Title: Executive Vice President & Chief Financial Officer |